Articles dans des revues avec comité de lecture (41)
  1. 13. Steele, C. D., Abbasi, A., S. M. Ashiqul, I., Khandekar, A., Haase, K., Hames, S., Tarabichi, M., Lesluyes, T., Flanagan, A. M., Mertens, F., Van Loo, P., Alexandrov, L. B., & Pillay, N. (2021). Signatures of copy number alterations in human cancer. BioRxiv. doi:10.1101/2021.04.30.441940
  2. 14. Dentro, S. C., Leshchiner, I., Haase, K., Tarabichi, M., Wintersinger, J. J., Deshwar, A. G., Yu, K., Rubanova, Y., Macintyre, G., Demeulemeester, J., Vázquez-García, I., Kleinheinz, K., Livitz, D. G., Malikic, S., Donmez, N., Sengupta, S., Anur, P., Jolly, C., Cmero, M., Rosebrock, D., Schumacher, S., Fan, Y., Fittall, M., Drews, R. M., Yao, X., Watkins, T. B. K., Lee, J., Schlesner, M., Zhu, H., Adams, D. J., McGranahan, N., Swanton, C., Getz, G., Boutros, P. C., Imielinski, M., Beroukhim, R., Sahinalp, C., Ji, Y., Peifer, M., Martincorena, I., Markowetz, F., Mustonen, V., Yuan, K., Gerstung, M., Spellman, P. T., Wang, W., Morris, Q. D., Wedge, D. C., & Van Loo, P. (2021). Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell, 184(8), 2239-2254.e39. doi:10.1016/j.cell.2021.03.009
  3. 15. Tarabichi, M., Demeulemeester, J., Verfaillie, A., Flanagan, A. M., Van Loo, P., & Konopka, T. (2021). A pan-cancer landscape of somatic mutations in non-unique regions of the human genome. Nature biotechnology. doi:10.1038/s41587-021-00971-y
  4. 16. Campbell, P. J., Sotiriou, C., Tarabichi, M., ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium,, et al. (2020). Pan-cancer analysis of whole genomes. Nature (London), 578(7793), 82-93. doi:10.1038/s41586-020-1969-6
  5. 17. Gerstung, M., Jolly, C., Leshchiner, I., Dentro, S., Gonzalez, S., Rosebrock, D., Mitchell, T. J., Rubanova, Y., Anur, P., Yu, K., Tarabichi, M., Deshwar, A., Wintersinger, J. J., Kleinheinz, K., Vázquez-García, I., Haase, K., Jerman, L., Sengupta, S., Macintyre, G., Malikic, S., Donmez, N., Livitz, D., Cmero, M., Demeulemeester, J., Schumacher, S., Fan, Y., Yao, X., Lee, J., Schlesner, M., Boutros, P., Bowtell, D., Zhu, H., Getz, G., Imielinski, M., Beroukhim, R., Sahinalp, C., Ji, Y., Peifer, M., Markowetz, F., Mustonen, V., Yuan, K., Wang, W., Morris, Q. D., Spellman, P., Wedge, D. C., & Van Loo, P. (2020). The evolutionary history of 2,658 cancers. Nature (London), 578(7793), 122-128. doi:10.1038/s41586-019-1907-7
  6. 18. Fittall, M. M., Lyskjaer, I., Ellery, P., Lombard, P., Ijaz, J., Strobl, A.-C., Oukrif, D., Tarabichi, M., Sill, M., Koelsche, C., Mechtersheimer, G., Demeulemeester, J., Tirabosco, R., Amary, F., Campbell, P. J., Pfister, S. M., Jones, D. T., Pillay, N., Van Loo, P., Behjati, S., & Flanagan, A. M. (2020). Drivers underpinning the malignant transformation of giant cell tumour of bone. Journal of pathology, 252(4), 433-440. doi:10.1002/path.5537
  7. 19. Rubanova, Y., Shi, R., Harrigan, C. C., Li, R., Wintersinger, J. J., Sahin, N., Deshwar, A., Tarabichi, M., Morris, Q., PCAWG, C., & PCAWG Evolution and Heterogeneity Working Group, (2020). Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nature communications, 11(1), 731. doi:10.1038/s41467-020-14352-7
  8. 20. Cmero, M., Yuan, K., Ong, C. S., Schröder, J., PCAWG Evolution and Heterogeneity Working Group,, Corcoran, N., Papenfuss, T., Hovens, C. C., Markowetz, F., Macintyre, G., Tarabichi, M., & PCAWG, C. (2020). Inferring structural variant cancer cell fraction. Nature communications, 11(1), 730. doi:10.1038/s41467-020-14351-8
  9. 21. Salcedo, A., Tarabichi, M., Espiritu, S. M. S., Deshwar, A. G., David, M., Wilson, N. M., Dentro, S., Wintersinger, J. J., Liu, L., Ko, M., Sivanandan, S., Zhang, H., Zhu, K., Ou Yang, T.-H., Chilton, J. J., Buchanan, A., Lalansingh, C. C., P'ng, C., Anghel, C. C., Umar, I., Lo, B., Zou, W., DREAM SMC-Het Participants,, Simpson, J. T., Stuart, J. M., Anastassiou, D., Guan, Y., Ewing, A. D., Ellrott, K., Wedge, D. C., Morris, Q., Van Loo, P., & Boutros, P. C. (2020). A community effort to create standards for evaluating tumor subclonal reconstruction. Nature biotechnology, 38(1), 97-107. doi:10.1038/s41587-019-0364-z
  10. 22. Li, C. H., Prokopec, S. S., Sun, R. X., Yousif, F., Schmitz, N., PCAWG Tumour Subtypes and Clinical Translation,, Boutros, P. C., Tarabichi, M., & PCAWG, C. (2020). Sex differences in oncogenic mutational processes. Nature communications, 11(1), 4330. doi:10.1038/s41467-020-17359-2
  11. 23. Perez-Rodriguez, D., Kalyva, M., Leija-Salazar, M., Lashley, T., Tarabichi, M., Chelban, V., Gentleman, S., Schottlaender, L., Franklin, H., Vasmatzis, G., Houlden, H., Schapira, A. H., Warner, T. T., Holton, J. L., Jaunmuktane, Z., & Proukakis, C. (2019). Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing. Acta neuropathologica communications, 7(1), 219. doi:10.1186/s40478-019-0873-5
  12. 24. Steele, C. D., Tarabichi, M., Oukrif, D., Webster, A. P., Ye, H., Fittall, M. M., Lombard, P., Martincorena, I., Tarpey, P. S., Collord, G., Haase, K., Strauss, S. J., Berisha, F., Vaikkinen, H., Dhami, P., Jansen, M., Behjati, S., Amary, F. M., Tirabosco, R., Feber, A., Campbell, P. J., Alexandrov, L. B., Van Loo, P., Flanagan, A. M., & Pillay, N. (2019). Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways. Cancer cell, 35(3), 441-456.e8. doi:10.1016/j.ccell.2019.02.002
    13. << Précédent 1 2 3 4 Suivant >>